Bright Minds Biosciences (DRUG) Other financing activities (2021 - 2026)
Bright Minds Biosciences (DRUG) posted Other financing activities of $31055.4 for Q1 2026, up 394.95% on a QoQ basis from $6274.5 in Q4 2025, and down 82.18% year-over-year from $174238.2 in Q1 2025.
Bright Minds Biosciences (DRUG) Other financing activities (2021 - 2026) Analysis & Trends
Bright Minds Biosciences' Other financing activities history runs 6 years deep, the most recent figure standing at $31055.4 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,055.41 |
| Mar 31, 2026 | 31,055.41 |
| Dec 31, 2025 | 6,274.50 |
| Dec 31, 2025 | 6,274.50 |
| Jun 30, 2025 | 6,314.98 |
| Jun 30, 2025 | 6,314.98 |
| Mar 31, 2025 | 174,238.18 |
| Mar 31, 2025 | 174,238.18 |
| Dec 31, 2024 | 665,801.98 |
| Dec 31, 2024 | 665,801.98 |
| Dec 31, 2023 | 661,081.97 |
| Dec 31, 2023 | 661,081.97 |
| Dec 31, 2022 | 186,709.99 |
| Dec 31, 2022 | 186,709.99 |
| Dec 31, 2021 | 93,811.99 |
| Dec 31, 2021 | 93,811.99 |
| Jun 30, 2021 | -19,037.35 |
| Jun 30, 2021 | -19,037.35 |